As a consequence, cilia are bent, and their beating becomes disordered. express a broad spectrum of pattern recognition receptors, enabling them to react to environmental stressors that overcome the mucosal barrier. By releasing alarminsproinflammatory and regulatory cytokinesAECs play an active role in the formation, strategic orientation, and control of the subsequent defense reaction. Consequently, the airway epithelium is usually of Etoricoxib D4 vital importance to chronic inflammatory diseases, such as asthma. Keywords:asthma, epithelium, inflammation, barrier, mucus, trained immunity, cytokines, IgA == 1. Introduction == The World Health Business (WHO) ranks chronic inflammatory diseases as among the greatest threats to human health since they represent the most significant cause of death worldwide and since their prevalence is still increasing. Among those chronic inflammatory diseases, bronchial asthma is the most common disease of the lung and affects more than 260 million people [1]. It is characterized by acute episodes of reversible broncho-obstruction and a number of symptoms, including chest tightness, coughing, shortness of breath, and wheezing [2]. Each of these symptoms may individually vary in duration, frequency, severity, and combination of occurrence. However, what they all have in common is usually that they arise on the basis of a chronic inflammatory response at the mucosal interface of the airways [3]. In theory, chronic inflammation can be regarded as an overreaction or permanent activation of the airway defense machinery. In healthy individuals, the defense system reacts to environmental stressors (e.g., pathogens) that harm or breach the epithelial boundary with a fine-tuned and adequate defensive response, and these reactions are downregulated once the offender has been taken care of. In asthma patients, however, mucosal homeostasis may become disturbed after a single trigger exposure and drift into the chronic inflammatory state upon repeated hits. Under certain circumstances, the latent inflammation aggravates suddenly, resulting in a perilous asthma exacerbation or status asthmaticus [4]. Amongst inducers of asthma attacks are exposure to pollutants and chemicals, tobacco smoking, and respiratory infections, but also psychological and environmental factors. As for disease initiation, it is important to note that asthma is not a single, homogeneous disease but rather a heterogeneous syndrome manifesting in different phenotypes, which are as yet not fully comprehended and characterized. For the development of the majority ofbut not allcases, current concepts of asthma pathogenesis propose a strong involvement of allergens. The allergen breaks through the barrier of the airway epithelium at some point in time and initiates an acute inflammatory response in the airway mucosa; subsequently, the inflammation may be reactivated upon further contact with an allergen. This subtype/endotype is called allergic asthma, whereby shifts and drifts between different allergic says are observed. Allergic asthma may start out from allergic reactions in the upper Etoricoxib D4 airways, such as hay fever, or it may develop from atopic dermatitis, where the main sites of inflammation switch from skin to airway mucosa, a phenomenon called atopic Etoricoxib D4 march [5,6]. Once Rabbit polyclonal to PRKAA1 established, allergic spectrum disorders usually bias T helper cell differentiation towards TH2 phenotype, and the latent inflammation that persists between acute episodes directs immune cells (e.g., eosinophils, neutrophils, TH2 lymphocytes, etc.) to stay at or migrate to inflamed sites, which results in a continuous stimulus of immune cell-derived proinflammatory mediators, such as certain cytokines or chemokines. This, in turn, fuels a vicious cycle of tissue repair and destruction, causing airway remodeling along with constant airway hyperresponsiveness (AHR) and prolonged mucus hyperproduction [7,8,9]. In contrast to the comparatively well-defined TH2-associated asthma phenotypes, a subset of asthma cases lacks common type 2 inflammation and cannot be assigned any specific biomarkers. Identification of this non-T2 asthma relies on common clinical features, such as airway obstruction and hyperresponsiveness, as well as sputum analysis. This phenotype is usually linked to strong neutrophilic airway inflammation [10,11]. Thus, no matter what asthma phenotype is present, the asthmatic airway mucosa stands in the crossfire of constant stimulus by immune cells from the inside and is challenged by microbes, noxae, allergens, and other foreign matter from Etoricoxib D4 the outside. Yet, the airway epithelium is not just a passive victim of this double-sided attack awaiting assaults hailing down.
Potassium Channels, Non-selective